Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy

Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib

(2017) I. Messaritakis et al.   LUNG CANCER

Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack

(2016) Michela Bulfoni et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Circulating tumor cells predict survival benefit from chemotherapy in patients with lung cancer

(2016) Zhuo-Xuan Wu et al.   Oncotarget

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer

(2016) Bo Ai et al.   Oncotarget

MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment

(2016) Kentaro Inamura et al.   Journal of Clinical Medicine

A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers

(2015) B. T. Li et al.   ANNALS OF ONCOLOGY

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

(2015) Claire Tissot et al.   EUROPEAN RESPIRATORY JOURNAL

Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC

(2015) Mario Mascalchi et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?

(2015) Bert Gold et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study

(2015) Denis Moro-Sibilot et al.   LUNG CANCER

Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancer

(2015) Zixuan Zhang et al.   RESPIROLOGY

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer

(2015) Annkathrin Hanssen et al.   Frontiers in Oncology

Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer

(2014) Angela Alama et al.   DRUG DISCOVERY TODAY

An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer

(2014) Maxim B. Freidin et al.   LUNG CANCER

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment

(2014) Laura Muinelo-Romay et al.   Cancers

Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System

(2014) Anna Truini et al.   Frontiers in Oncology

Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine

(2013) O. Juan et al.   Clinical & Translational Oncology

Pemetrexed for the treatment of non-small cell lung cancer

(2013) Carlo Genova et al.   EXPERT OPINION ON PHARMACOTHERAPY

EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics

(2013) M. E. Arcila et al.   MOLECULAR CANCER THERAPEUTICS

Levels of cell-free DNA and plasma KRAS during treatment of advanced NSCLC

(2013) ANNELI DOWLER NYGAARD et al.   ONCOLOGY REPORTS

Plasticity of disseminating cancer cells in patients with epithelial malignancies

(2012) Natalia Bednarz-Knoll et al.   CANCER AND METASTASIS REVIEWS

The impact of non-tumor-derived circulating nucleic acids implicates the prognosis of non-small cell lung cancer

(2012) Chanida Vinayanuwattikun et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Relationship of Circulating Tumor Cells to the Effectiveness of Cytotoxic Chemotherapy in Patients With Metastatic Non-Small-Cell Lung Cancer

(2012) Takashi Hirose et al.   ONCOLOGY RESEARCH

Circulating Cell-Free DNA in Plasma of Never Smokers with Advanced Lung Adenocarcinoma Receiving Gefitinib or Standard Chemotherapy as First-Line Therapy

(2011) Y. J. Lee et al.   CLINICAL CANCER RESEARCH

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

(2011) Matthew G. Krebs et al.   JOURNAL OF CLINICAL ONCOLOGY

A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer

(2011) José Rodrigues-Pereira et al.   Journal of Thoracic Oncology

Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer

(2011) Rafael Sirera et al.   Journal of Thoracic Oncology

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

(2011) Matthew G. Krebs et al.   Journal of Thoracic Oncology

Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer

(2010) S. Kumar et al.   EUROPEAN RESPIRATORY JOURNAL

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

(2008) J. S. de Bono et al.   CLINICAL CANCER RESEARCH

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal Cancer

(2008) Steven J. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY